Skip to main content

Gastric Cancer OnlineFirst articles

13.03.2018 | Original Article

Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis

Although gastric cancer is still a leading cause of cancer death worldwide [ 1 ], most early gastric cancer (EGC) patients have a favorable prognosis with low tumor recurrence rate and long survival time after an appropriate surgical treatment [ 2 …

13.03.2018 | Original Article

A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial

Peritoneal metastasis is one of the most frequent causes of recurrence and death among patients with advanced gastric cancer and often occurs after D2 gastrectomy which is considered to confer excellent local control [ 1 ]. Disseminated nodules can …

13.03.2018 | Original Article

Diagnostic accuracy of demarcation using magnifying endoscopy with narrow-band imaging for Helicobacter pylori-uninfected undifferentiated-type early gastric cancer

Since the indications for endoscopic submucosal dissection (ESD) were expanded to include undifferentiated-type early gastric cancers (UD-type EGCs) [ 1 – 3 ], improvements in preoperative diagnostic ability have been a concern. Diagnosis of …

07.03.2018 | Original Article

Quantitative assessment of fluorescence intensity of ICG in sentinel nodes in early gastric cancer

Since gastrectomy with D2 lymph node dissection became the standard procedure for gastric cancer worldwide, its prognosis has improved [ 2 ]. Gastric cancer is now discovered in the early stages in many cases due to recent advances in endoscopic …

05.03.2018 | Original Article

Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study

Gastric cancer is the most common type of cancer in Japan and is associated with a poor prognosis. Of note, the incidence and age-adjusted incidence of gastric cancer in Japan in 2012 were 107,898 and 29.9 per 100,000, respectively [ 1 ]. In …

Weitere Informationen

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.